Key Finding
HJ11 Chinese herbal formula reduced atherosclerotic plaque formation and inflammation by modulating gut microbiota, specifically promoting beneficial Akkermansia bacteria, and inhibiting the TLR4/MYD88/IκB-α inflammatory signaling pathway.
Researchers investigating heart disease have found that a traditional Chinese herbal formula called HJ11 may help protect against atherosclerosis, the dangerous buildup of plaque in arteries. This study focused on how the formula works through the gut-heart connection, examining mice bred to develop atherosclerosis similar to humans with coronary artery disease. The researchers discovered that HJ11 worked in multiple beneficial ways: it reduced harmful cholesterol levels in the blood, decreased plaque formation in arteries, and reduced inflammation in blood vessels. Importantly, the formula also improved gut health by repairing intestinal damage and strengthening the gut barrier. It specifically promoted the growth of Akkermansia, a beneficial gut bacteria known to support cardiovascular health. The study found that HJ11 works by blocking a specific inflammatory pathway in cells called TLR4/MyD88/IκB-α, which plays a key role in atherosclerosis development. This research adds to growing evidence that the health of our gut microbiome significantly affects our cardiovascular system. While this study used an animal model and laboratory cell cultures rather than human subjects, it provides important insights into how traditional Chinese herbal formulas may complement conventional heart disease treatments by addressing both cardiovascular inflammation and gut health simultaneously. The findings suggest potential benefits with minimal side effects compared to some pharmaceutical approaches. If you're interested in exploring Chinese herbal medicine for cardiovascular support, consult with a qualified, licensed practitioner who can assess your individual needs.
This preclinical study investigated the Chinese herbal formula HJ11 using ApoE-/- atherosclerotic mice treated via gavage, alongside in vitro atherosclerosis models. Using 16S rDNA sequencing and metabolomics, researchers demonstrated that HJ11 significantly reduced serum lipid levels, plaque formation, vascular inflammation, and collagen deposition while improving aortic integrity. The formula enhanced intestinal barrier function and repaired structural gut damage. Microbiome analysis revealed HJ11 promoted Akkermansia proliferation, a beneficial bacterium that modulates TLR4 expression. Mechanistically, HJ11 suppressed endothelial inflammation and vascular smooth muscle cell proliferation by inactivating the TLR4/MYD88/IκB-α signaling pathway—effects abolished by TLR4 overexpression in vitro. Clinical implications: This research validates the heart-gut axis as a therapeutic target and supports HJ11's traditional use for coronary artery disease through multi-pathway modulation. The findings suggest gut microbiota modulation represents a viable adjunctive strategy for atherosclerosis management, warranting clinical trials.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 QSYQ formula improved heart failure outcomes in mice by restoring myocardial energy metabolism through AMPK pathway activation, increasing ATP production while reducing oxidative stress and improving cardiac function.
📌 Chinese herbal medicine use in chronic kidney disease patients was associated with a 23-31% reduction in risk of major adverse cardiac events and all-cause mortality over a 17-year follow-up period.
📌 Six food and medicine homology plants demonstrate multi-target therapeutic mechanisms in coronary heart disease through immunomodulation, particularly affecting CD4+ memory activated T cells and naïve B cells, with four hub genes showing validated causal associations with CHD.